Vamil Divan

Dr. Vamil Divan is a Managing Director & Equity Research Analyst at Guggenheim Securities LLC.
He covers the Global Biopharmaceutical and Biotechnology sectors.
Dr. Divan has more than 25 years of experience in the healthcare industry, including 17 years in Equity Research.
Prior to joining the firm, Dr. Divan was a Senior Analyst at Mizuho Securities and prior to that he spent over a decade at Credit Suisse covering various Biopharma companies.
Before transitioning to Wall Street, Dr. Divan worked in the pharmaceutical industry at Pfizer and Roche, after starting his career as an Internal Medicine physician working in an outpatient-based practice in New York City.
Dr. Divan earned his B.S.
from the Wharton School of Business at the University of Pennsylvania, his M.D.
degree from the University of Buffalo, and his M.B.A. from the Stern School of Business at New York University.